Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Sorrento Therapeutics, a San Diego-China biopharma,...
China Resources Pharma's $2 billion IPO, which will be...
Shanghai Pharma may bid $4 billion to acquire Stada, a...
Deals and Financings
- OrbiMed closed its third Asia...
Deals and Financings
Hua Medicine will raise $200...
Deals and Fundings
Sinocare of Changsha may bid as...
Refuge Biotechnologies, a cell therapy company based in...
Deals and Financings
Apollomics, a Hangzhou...
Deals and Financings
• CStone Pharma of Suzhou will...
Deals and Financings
• Grifols of Barcelona...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
